Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

This review will delve deep into what makes ... Viraldine is a powerful nasal and throat spray formulated with USP Povidone-Iodine, designed to cleanse your respiratory system effectively.

Approval of Spravato, granted following FDA priority review, was based on the results of a randomized ... compared with 7.6 percent of patients taking placebo. Spravato nasal spray is administered by ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...

The nasal spray has undergone more than a decade of ... NEW YORK, Jan. 31 (UPI) -- A study that reviews the sodium and nutritional content of foods promoted during timeouts and halftime found ...

This NDA acceptance represents a pivotal milestone for Corstasis Therapeutics, signifying the FDA’s determination that the ...

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...